Reuters logo
8 months ago
BRIEF-Biotime says now has more than 50 patients in renevia pivotal trial
December 14, 2016 / 12:12 PM / 8 months ago

BRIEF-Biotime says now has more than 50 patients in renevia pivotal trial

Dec 14 (Reuters) - Biotime Inc

* Biotime Inc says it has achieved an important patient enrollment milestone in its renevia pivotal trial in europe

* Biotime Inc - remains on track for top-line data by middle of 2017 for renevia pivotal study

* Biotime achieves patient recruitment milestone in renevia pivotal trial

* Biotime Inc says now has more than 50 patients in trial, keeping it on track with anticipated forecast for top-line data by middle of 2017

* Biotime Inc says remains on track for top-line data by middle of 2017

* Biotime Inc - also actively working on plans for other large aesthetic markets like South Korea and Brazil as well as U.S for renevia Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below